Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Montalban, X."" wg kryterium: Wszystkie pola


Tytuł:
Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial.
Autorzy:
Bar-Or A; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .
Montalban X; Department of Neurology-Neuroimmunology and Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Hu X; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Kropshofer H; Novartis Pharma AG, Basel, Switzerland.
Kukkaro P; Novartis Pharma AG, Basel, Switzerland.
Coello N; Novartis Pharma AG, Basel, Switzerland.
Ludwig I; Novartis Pharma AG, Basel, Switzerland.
Willi R; Novartis Pharma AG, Basel, Switzerland.
Zalesak M; Novartis Pharma AG, Basel, Switzerland.
Ramanathan K; Novartis Pharma AG, Basel, Switzerland.
Kieseier BC; Novartis Pharma AG, Basel, Switzerland.; Department of Neurology, Medical Faculty, Heinrich-Heine University, Dusseldorf, Germany.
Häring DA; Novartis Pharma AG, Basel, Switzerland.
Bagger M; Novartis Pharma AG, Basel, Switzerland.
Fox E; Central Texas Neurology Consultants and Dell Medical School, The University of Texas at Austin, Round Rock, Austin, TX, USA.
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2023 Feb; Vol. 12 (1), pp. 303-317. Date of Electronic Publication: 2022 Dec 19.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Liquid Biopsy in Neurological Diseases.
Autorzy:
Malhotra S; Multiple Sclerosis Center of Catalonia, Department of Neurology-Neuroimmunology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Miras MCM; Multiple Sclerosis Center of Catalonia, Department of Neurology-Neuroimmunology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Pappolla A; Multiple Sclerosis Center of Catalonia, Department of Neurology-Neuroimmunology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Montalban X; Multiple Sclerosis Center of Catalonia, Department of Neurology-Neuroimmunology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Comabella M; Multiple Sclerosis Center of Catalonia, Department of Neurology-Neuroimmunology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Jul 22; Vol. 12 (14). Date of Electronic Publication: 2023 Jul 22.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell-Free Nucleic Acids*
MicroRNAs*
Central Nervous System Neoplasms*
Humans ; Liquid Biopsy/methods ; Biomarkers
Czasopismo naukowe
Tytuł:
Real-world evaluation of ocrelizumab in multiple sclerosis: A systematic review.
Autorzy:
Montalban X; Department of Neurology, Centre d'Esclerosi Mútiple de Catalunya (Cemcat), Barcelona, Spain.
Matthews PM; Department of Brain Sciences, UK Dementia Research Institute Centre at Imperial College London, London, UK.
Simpson A; F. Hoffmann-La Roche, Global Access, Basel, Switzerland.
Petrie JL; PHMR Ltd, Berkley Grove, London, UK.
Sammon C; PHMR Ltd, Berkley Grove, London, UK.
Ramagopalan S; F. Hoffmann-La Roche, Global Access, Basel, Switzerland.
Disanto G; Ente Ospedaliero Cantonale (EOC), Lugano, Ticino, Switzerland.
Kuhle J; Department of Neurology, University Hospital, University of Basel, Basel, Switzerland.; Departments of Biomedicine and Clinical Research, Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), University Hospital, University of Basel, Basel, Switzerland.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 Mar; Vol. 10 (3), pp. 302-311. Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Systematic Review; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Sclerosis*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Chronic Progressive*/drug therapy
Humans ; Immunologic Factors/pharmacology ; Immunologic Factors/therapeutic use ; Recurrence
Czasopismo naukowe
Tytuł:
Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosis.
Autorzy:
Graves JS; Department of Neurosciences, University of California San Diego, San Diego, California, USA.
Ganzetti M; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Dondelinger F; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Lipsmeier F; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Belachew S; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Bernasconi C; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Montalban X; Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
van Beek J; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Baker M; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Gossens C; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Lindemann M; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 Feb; Vol. 10 (2), pp. 166-180. Date of Electronic Publication: 2022 Dec 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Sclerosis*/diagnostic imaging
Humans ; Upper Extremity ; Magnetic Resonance Imaging ; Smartphone ; Brain
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies